CD47 and Miyoshi myopathy: Single-cell atlas of the immune microenvironment reveals macrophage reprogramming and the potential dual macrophage-targeted strategy in MM by combining an anti-CD47 antibody and MIF (macrophage inhibitory factor) inhibition.